Wednesday, 14 October 2026European Markets

ELKEM, ASSYSTEM, Another 5 Companies Have A High Estimated Dividend Yield

Loading stream...

(vianews) - elkem (elk.ol), assystem (asy.pa), antin infra partn (antin.pa) have the highest dividend yield stocks on this list.

financial asset forward dividend yield updated (est)
elkem (elk.ol) 25.91% 2024-10-27 11:20:23
assystem (asy.pa) 16.34% 2024-10-27 11:35:56
antin infra partn (antin.pa) 5.77% 2024-10-27 11:35:45
entra (entra.ol) 5.15% 2024-10-27 11:20:33
entra (entra.ol) 5.15% 2024-10-27 11:20:33
atland (atld.pa) 5.11% 2024-10-27 11:36:00
maroc telecom (iam.pa) 4.6% 2024-10-27 11:50:27

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. elkem (elk.ol)

25.91% foward dividend yield

elkem's last close was kr18.78, 54.7% under its 52-week high of kr41.46. intraday change was -0.43%.

earnings per share

as for profitability, elkem has a trailing twelve months eps of kr-0.8.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.37%.

more news about elkem.

2. assystem (asy.pa)

16.34% foward dividend yield

assystem's last close was €47.25, 22.79% below its 52-week high of €61.20. intraday change was 0.42%.

earnings per share

as for profitability, assystem has a trailing twelve months eps of €6.79.

pe ratio

assystem has a trailing twelve months price to earnings ratio of 6.99. meaning, the purchaser of the share is investing €6.99 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.25%.

volume

today's last reported volume for assystem is 5573 which is 57.01% below its average volume of 12966.

moving average

assystem's value is way below its 50-day moving average of €55.02 and below its 200-day moving average of €51.05.

volatility

assystem's last week, last month's, and last quarter's current intraday variation average was a negative 2.22%, a positive 0.06%, and a positive 1.60%.

assystem's highest amplitude of average volatility was 2.22% (last week), 1.29% (last month), and 1.60% (last quarter).

dividend yield

as stated by morningstar, inc., the next dividend payment is on jul 10, 2024, the estimated forward annual dividend rate is 8 and the estimated forward annual dividend yield is 16.34%.

more news about assystem.

3. antin infra partn (antin.pa)

5.77% foward dividend yield

antin infra partn's last close was €10.46, 39.47% below its 52-week high of €17.28. intraday change was -1.52%.

earnings per share

as for profitability, antin infra partn has a trailing twelve months eps of €0.65.

pe ratio

antin infra partn has a trailing twelve months price to earnings ratio of 15.85. meaning, the purchaser of the share is investing €15.85 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.4%.

yearly top and bottom value

antin infra partn's stock is valued at €10.30 at 01:50 est, way under its 52-week high of €17.28 and higher than its 52-week low of €10.10.

more news about antin infra partn.

4. entra (entra.ol)

5.15% foward dividend yield

entra's last close was kr121.60, 9.93% below its 52-week high of kr135.00. intraday change was -0.99%.

earnings per share

as for profitability, entra has a trailing twelve months eps of kr-19.33.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -13.66%.

more news about entra.

5. entra (entra.ol)

5.15% foward dividend yield

entra's last close was kr121.60, 9.93% below its 52-week high of kr135.00. intraday change was -0.99%.

earnings per share

as for profitability, entra has a trailing twelve months eps of kr-19.33.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -13.66%.

moving average

entra's worth is way above its 50-day moving average of kr97.87 and way above its 200-day moving average of kr105.24.

more news about entra.

6. atland (atld.pa)

5.11% foward dividend yield

atland's last close was €43.40, 23.19% below its 52-week high of €56.50. intraday change was -0.91%.

earnings per share

as for profitability, atland has a trailing twelve months eps of €2.19.

pe ratio

atland has a trailing twelve months price to earnings ratio of 19.82. meaning, the purchaser of the share is investing €19.82 for every euro of annual earnings.

more news about atland.

7. maroc telecom (iam.pa)

4.6% foward dividend yield

maroc telecom's last close was €8.25, 14.51% under its 52-week high of €9.65. intraday change was 1.68%.

earnings per share

as for profitability, maroc telecom has a trailing twelve months eps of €0.53.

pe ratio

maroc telecom has a trailing twelve months price to earnings ratio of 17.17. meaning, the purchaser of the share is investing €17.17 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.58%.

yearly top and bottom value

maroc telecom's stock is valued at €9.10 at 01:50 est, below its 52-week high of €9.65 and way above its 52-week low of €7.80.

moving average

maroc telecom's worth is way above its 50-day moving average of €8.21 and above its 200-day moving average of €8.43.

revenue growth

year-on-year quarterly revenue growth declined by 0.8%, now sitting on 36.65b for the twelve trailing months.

more news about maroc telecom.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com